University of Twente
You will be part of the highly multidisciplinary consortium NANOSPRESSO-NL (8 M€). We aim to study, develop, and implement a disruptive technology for decentralized and small-scale bedside production of high quality and affordable nucleic acid nanomedicines for the treatment of orphan (rare) diseases. The technology is based on the microfluidic formation of lipid nanoparticles (LNPs) that carry nucleic acid therapeutics such as mRNA. The microfluidic formation of LNPs is achieved when a stream of lipids (surfactants) dissolved in ethanol is mixed with water such that the solubility of the lipids decreases below a critical threshold at which the lipids and therapeutics phase separate and self-assemble into LNPs (~100 nm diameter). This is very similar but much more complex to a famous fluid dynamical problem: The Ouzo (Greek alcoholic drink) effect where nano- and microdroplets of oil nucleate when the Ouzo is diluted with water. Your task within this project is to unravel the coupling between the fluid mechanics of the convective and diffusive mixing and the physicochemistry of the self-assembly of the lipid and therapeutic molecules. You will thus work on the fundamentals of LNP formation with the ultimate aim to develop understanding required to allow bottom-up design of microfluidic devices and operating conditions tailored to specific needs in terms of LNP size distribution and therapeutic loading. To gain understanding, you will design and fabricate microfluidic chips and you will be trained to master a broad range of experimental techniques including ultra-high-speed (fluorescence) imaging at the sub-µs timescale and confocal imaging. Whenever possible, you will develop hand in hand with the experiments accompanying numerical simulations and theory to test our understanding.
The NANOSPRESSO-NL consortium works on all aspects of brining personalized LNP therapeutics to the clinic starting at understanding the microfluidic formation of LNPs (you), the development of novel microfluidic devices (you), the implementation of the microfluidic devices in a cartridge containing all fluids (analogous to a Nespresso cup), the development of a tabletop device that can operate the cartridge (Nespresso coffee machine), cell and preclinical experiments, to all legislation related to bringing new medicine to the market. This is thus a unique opportunity to develop deep fundamental physicochemical (hydrodynamic) understanding of LNP self-assembly with the possibility to achieve a relatively short-term impact while gaining insight in all aspects that play a role in the development of new pharmaceutical products.
You will be embedded in the dynamic BIOS/Lab on a Chip group, which is part of the Max Planck Center Twente for Complex Fluid Dynamics, the J.M. Burgers Research Center for Fluid Mechanics (JMBC), and the MESA+ Institute for Nanotechnology. You will closely collaborate with the Laboratory for Clinical Chemistry & Hematology of the University Medical Center Utrecht (Prof. Dr. Raymond Schiffelers), with SINTEF in Trondheim (Norway), as well as with a pharmaceutical spin off company of the UT (Solstice Pharmaceuticals). Your direct colleagues in the BIOS group are active and organize many after-work activities.
Your profile
Our offer